India's Serum Institute exports first Novavax shot

·1-min read
A vial and a syringe are seen in front of a displayed Novavax logo, in this illustration taken

(This November 30 story corrects officially to remove reference to COVAX from headline and lead after Indian government clarifies it was a bilateral deal between Serum and Indonesia)

NEW DELHI (Reuters) - Serum Institute of India has sent doses of COVID-19 vaccine to Indonesia, in its first export of the Novavax shot, the Indian government said on Wednesday.

The world's biggest vaccine maker exported 137,500 doses of Covovax, as it calls the shot, to the Southeast Asian country last week.

Indonesia has approved the vaccine but India and the World Health Organization have not.

(Reporting by Krishna N. Das; Editing by Clarence Fernandez)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting